Article: Enhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleEnhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis
AuthorsShi, Y1 2
Sandoghchian Shotorbani, S1
Su, Z1
Liu, Y1
Tong, J1
Zheng, D1
Chen, J1
Liu, Y1
Xu, Y1
Jiao, Z1
Wang, S1
Lu, L1
Huang, X1
Xu, H1
Issue Date2012
PublisherHindawi Publishing Corporation. The Journal's web site is located at http://www.hindawi.com/journals/cdi/
CitationClinical & Developmental Immunology, 2012, v. 2012, article no. 295081 [How to Cite?]
DOI: http://dx.doi.org/10.1155/2012/295081
AbstractRheumatoid arthritis(RA) is a common autoimmune disease associated with Th17 cells, but what about the effect of high-mobility group box chromosomal protein 1 (HMGB1) and the relationship between Th17-associated factors and HMGB1 in RA remains unknown. In the present study, we investigated the mRNA levels of HMGB1, RORgammat, and IL-17 in peripheral blood mononuclear cells (PBMCs) from patients with rheumatoid arthritis by quantitative real-time PCR (RT-qPCR), and the concentrations of HMGB1, IL-17, and IL-23 in plasma were detected by ELISA. And then, the effect of HMGB1 on Th17 cells differentiation was analyzed in vitro. Our clinical studies showed that the mRNAs of HMGB1, RORgammat, and IL-17 in patients were higher than that in health control (P < 0.05), especially in active RA patients (P < 0.05). The plasma HMGB1, IL-17, and IL-23 in RA patients were also higher than that in health control (P < 0.05); there was a positive correlation between the expression levels of HMGB1 and the amount of CRP, ERS, and RF in plasma. In vitro, the IL-17-produced CD4(+)T cells were increased with 100 ng/mL rHMGB1 for 12h, which indicated that the increased HMGB1 might contribute to Th17 cells activation in RA patients.
ISSN1740-2522
2011 Impact Factor: 1.838
2011 SCImago Journal Rankings: 0.180
DOIhttp://dx.doi.org/10.1155/2012/295081
PubMed Central IDPMC3205666
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorShi, Y
dc.contributor.authorSandoghchian Shotorbani, S
dc.contributor.authorSu, Z
dc.contributor.authorLiu, Y
dc.contributor.authorTong, J
dc.contributor.authorZheng, D
dc.contributor.authorChen, J
dc.contributor.authorLiu, Y
dc.contributor.authorXu, Y
dc.contributor.authorJiao, Z
dc.contributor.authorWang, S
dc.contributor.authorLu, L
dc.contributor.authorHuang, X
dc.contributor.authorXu, H
dc.date.accessioned2012-05-29T06:14:36Z
dc.date.available2012-05-29T06:14:36Z
dc.date.issued2012
dc.description.abstractRheumatoid arthritis(RA) is a common autoimmune disease associated with Th17 cells, but what about the effect of high-mobility group box chromosomal protein 1 (HMGB1) and the relationship between Th17-associated factors and HMGB1 in RA remains unknown. In the present study, we investigated the mRNA levels of HMGB1, RORgammat, and IL-17 in peripheral blood mononuclear cells (PBMCs) from patients with rheumatoid arthritis by quantitative real-time PCR (RT-qPCR), and the concentrations of HMGB1, IL-17, and IL-23 in plasma were detected by ELISA. And then, the effect of HMGB1 on Th17 cells differentiation was analyzed in vitro. Our clinical studies showed that the mRNAs of HMGB1, RORgammat, and IL-17 in patients were higher than that in health control (P < 0.05), especially in active RA patients (P < 0.05). The plasma HMGB1, IL-17, and IL-23 in RA patients were also higher than that in health control (P < 0.05); there was a positive correlation between the expression levels of HMGB1 and the amount of CRP, ERS, and RF in plasma. In vitro, the IL-17-produced CD4(+)T cells were increased with 100 ng/mL rHMGB1 for 12h, which indicated that the increased HMGB1 might contribute to Th17 cells activation in RA patients.
dc.description.naturepublished_or_final_version
dc.identifier.citationClinical & Developmental Immunology, 2012, v. 2012, article no. 295081 [How to Cite?]
DOI: http://dx.doi.org/10.1155/2012/295081
dc.identifier.doihttp://dx.doi.org/10.1155/2012/295081
dc.identifier.hkuros208181
dc.identifier.issn1740-2522
2011 Impact Factor: 1.838
2011 SCImago Journal Rankings: 0.180
dc.identifier.pmcidPMC3205666
dc.identifier.pmid22110531
dc.identifier.scopuseid_2-s2.0-84855173538
dc.identifier.urihttp://hdl.handle.net/10722/148675
dc.identifier.volume2012, article no. 295081
dc.languageeng
dc.publisherHindawi Publishing Corporation. The Journal's web site is located at http://www.hindawi.com/journals/cdi/
dc.publisher.placeUnited States
dc.relation.ispartofClinical & Developmental Immunology
dc.relation.referencesReferences in Scopus
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License
dc.subject.meshArthritis, Rheumatoid - genetics - immunology - metabolism
dc.subject.meshCD4-Positive T-Lymphocytes - immunology
dc.subject.meshHMGB1 Protein - genetics - metabolism
dc.subject.meshLymphocyte Activation - immunology
dc.subject.meshTh17 Cells - immunology
dc.titleEnhanced HMGB1 expression may contribute to Th17 cells activation in rheumatoid arthritis
dc.typeArticle
Author Affiliations
  1. Jiangsu University
  2. Suzhou Municipal Hospital